MINOCYCLINE HYDROCHLORIDE
| Brand name | ZILXI |
|---|---|
| Active ingredient | MINOCYCLINE HYDROCHLORIDE |
| Strength | EQ 1.5% BASE |
| Dosage form | AEROSOL, FOAM |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | May 2020 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12661407 | October 2030 | use U-1631 |
| 10213512 | October 2030 | product |
| 8992896 | October 2030 | product |
| 9675700 | October 2030 | product |
| 8865139 | October 2030 | product |
| 10322186 | October 2030 | use U-1631 |
| 10946101 | October 2030 | use U-1631 |
| 12138311 | October 2030 | use U-1631 |
| 10265404 | October 2030 | product |
| 8945516 | October 2030 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.